Vrtx stock price.

Stock Price Forecast ... The 26 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 394.00, with a high estimate of ...View the latest Vertex Pharmaceuticals Inc. (VRTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.The VRTX stock price slipped in after-hours trading, but it was up over 10% in the week and 19% for the year leading up to earnings. If I was an investor, I’d be looking into the reason why.This partnership, forged in the wake of impressive clinical data, saw Gilead investing massively in Arcellx, with $225 million in cash and a $100 million stock purchase. Moreover, Arcellx’s ...

Find the latest Vortex Energy Corp. (VTECF) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 1, 2023 · According to 25 stock analysts, the average 12-month stock price forecast for VRTX stock stock is $372.96, which predicts a decrease of -0.18%. The lowest target is $245 and the highest is $456. On average, analysts rate VRTX stock stock as a buy.

Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 27, 2023 · 2021. 219.6. 2022. 288.78. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The latest closing stock price for Vertex Pharmaceuticals as of November 30, 2023 is 354.81. The all-time high Vertex Pharmaceuticals stock closing price was 385.76 on November 06, 2023. The Vertex Pharmaceuticals 52-week high stock price is 387.42, which is 9.2% above the current share price. The Vertex Pharmaceuticals 52-week low stock price ...The price-to-earnings ratio for Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) is above average at 26.34x. The 36-month beta value for VRTX is also noteworthy at 0.41. There are mixed opinions on the stock, with 19 analysts rating it as a “buy,” 3 rating it as “overweight,” 9 rating it as “hold,” and 0 rating it as “sell.”.In 2022, Pfizer reported revenue of $100.3 billion, including Covid-19 treatment revenue of $56.74 billion. Excluding the impact of COVID-19-related revenue, Pfizer would have reported revenue of ...

Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.

The latest price target for . Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Stifel on Wednesday, November 22, 2023.The analyst firm set a price target for 373.00 expecting VRTX to rise to ...

The price-to-earnings ratio for Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) is above average at 26.34x. The 36-month beta value for VRTX is also noteworthy at 0.41. There are mixed opinions on the stock, with 19 analysts rating it as a “buy,” 3 rating it as “overweight,” 9 rating it as “hold,” and 0 rating it as “sell.”.VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move. November 7, 2023 7:05 pm EST. stock. WBI Share Price Crashes Below 1 GBX, Analysts Hope For A Recovery. November 7, 2023 6:33 pm EST. stock. LRCX Stock Price Prediction 2023-25: Is LRCX Ready to Outperform?Vortex Energy Corp. (VRTX.CNSX) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Vortex Energy Corp. | Canadian Securities Exchange ...Based on short-term price targets offered by 23 analysts, the average price target for Vertex Pharmaceuticals comes to $392.65. The forecasts range from a low of $315.00 to a high of $456.00. The ...Vertex Pharmaceuticals (VRTX 1.08%) ... The stock has generally gained over time, too. ... Vertex hasn't yet set a price for exa-cel, but the cost of treatment in the U.S. for one sickle cell ...In the current market session, Vertex Pharmaceuticals Inc. VRTX stock price is at $355.94, after a 0.31% drop. However, over the past month, the company's stock spiked by 2.54%, ...0.00. Vertex Pharmaceuticals Inc (VRTX) - Symdeko / Symkevi Revenue. 31.20M. Vertex Pharmaceuticals Inc (VRTX) - Trikafta / Kaftrio Revenue. 2.240B. In depth view into VRTX (Vertex Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

To be clear, that's not a certain bet -- there is hardly such a thing on the stock market. However, CRISPR Therapeutics has now proven that it can develop a breakthrough therapy, and is on its way ...Vertex currently has an average brokerage recommendation (ABR) of 1.59, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc ...Find the latest Intel Corporation (INTC) stock quote, history, news and other vital information to help you with your stock trading and investing.Vertex Pharmaceuticals stock is buoyed by recent approval of Kalydeco for an additional indication.Oct 2, 2023 · The lower the Forward P/E, the cheaper the stock. VRTX’s price/book is 5.96. Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on ...

Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... The current price Vertex Pharmaceuticals (VRTX) is trading at is $351.16, ...

Real-time Price Updates for Vertex Pharmaceutic (VRTX-Q), along with buy or sell ... 5 Bullish Stocks For Covered Calls, Puts Stock Options Trades. November 5 ...According to 25 stock analysts, the average 12-month stock price forecast for VRTX stock stock is $372.96, which predicts an increase of 6.21%. The lowest target is $245 and the highest is $456. On average, analysts rate VRTX stock stock as a buy. Analyst Consensus: Buy. Target Low Average Median High; Price: $245: $372.96: $380: …Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock news and headlines to help you in your trading and investing decisions.Vertex Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target VRTX. High $ 456.00: Median $ 394.00: Low $ 325.00: Average $ 399.46 ... Dec 1, 2023 · According to 27 analysts, the average rating for VRTX stock is "Buy." The 12-month stock price forecast is $372.96, which is an increase of 6.21% from the latest price. According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 1, 2023 · According to 25 stock analysts, the average 12-month stock price forecast for VRTX stock stock is $372.96, which predicts a decrease of -0.18%. The lowest target is $245 and the highest is $456. On average, analysts rate VRTX stock stock as a buy. Per the technicals, VRTX stock has persisted in forming higher highs and rewarding investors. If the bulls continue to charge, VRTX stock would have the potential to reach a maximum of $450 followed by $460. However, if the stock falls below $350, the stock will retest the round mark of $300 soon. VRTX Stock Price Prediction 2025Nov 30, 2023 · Vertex Pharmaceuticals Inc Stock Forecast and Price Target The average target price for Vertex Pharmaceuticals Inc's stock set by eighteen renowned analysts in recent months is $390.00, representing a potential upside of approximately 11.11% from its last closing price if met by 2024.

VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Vertex Pharmaceuticals (VRTX) is a biotechnology company that develops treatments for rare diseases. The stock price, news, analysis and ratings of VRTX are …

Nov 29, 2023 · Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $89.75B. +20.9%. Market Cap / Employee. The market cap of a ... 72.84. -2.72%. 7.62M. View today's Vertex Pharmaceuticals Inc stock price and latest VRTX news and analysis. Create real-time notifications to follow any changes in the live …Find the latest Vortex Energy Corp. (VRTX.CN) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 394.00, with a high estimate of 456.00 and a low estimate of 325.00 ...VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move. November 7, 2023 7:05 pm EST. stock. WBI Share Price Crashes Below 1 GBX, Analysts Hope For A Recovery. November 7, 2023 6:33 pm EST. stock. LRCX Stock Price Prediction 2023-25: Is LRCX Ready to Outperform?Research Vertex Pharmaceuticals' (Nasdaq:VRTX) stock key valuation metrics while comparing it with its industry peers & market side by side ... The above table shows the analyst VRTX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...Find the latest Vertiv Holdings Co (VRT) stock quote, history, news and other vital information to help you with your stock trading and investing.Vertex Pharmaceuticals (VRTX) closed at $317.27 in the latest trading session, marking a -1.8% move from the prior day. This change lagged the S&P 500's 1.05% gain on the day. Elsewhere, the Dow ...About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Vertex Pharmaceuticals Incorporated Common Stock (VRTX ... Insider Sell Alert: EVP and CMO Carmen Bozic Sells 5,650 Shares of Vertex Pharmaceuticals Inc (VRTX) (GuruFocus.com) Nov-16-23 07:05PM. Analyst Report: Vertex Pharmaceuticals Incorporated. (Morningstar Research) 04:06PM. Market Today: CRISPR Therapeutics and Vertex Pharmaceuticals Make History with UK Drug Approval. Mar 2, 2023 · The US$332 analyst price target for VRTX is 23% less than our estimate of fair value. ... the company appears quite good value at a 32% discount to where the stock price trades currently ... Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find out why VRTX stock is a Buy. ... Morningstar set a far more conservative Fair Value Estimate of $314, which is substantially below the current market price of VRTX. Reply Like (3) c. chipb.Conversely, if more people wanted to sell a stock than buy it, there would be greater supply than demand, and the price would fall. VRTX 354.81 +3.81(1.09%) Will VRTX be a Portfolio Killer in ...-EU and UK filings completed in 2022; submissions validated by EMA and MHRA and the review procedure has begun as of January 2023-. BOSTON & ZUG, Switzerland--(BUSINESS WIRE)--Apr. 3, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced the …Instagram:https://instagram. option pricing softwarenysearca bilfan duel floridaoptions simulation trading Vertex Pharmaceuticals Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030 In the last three years, EPS for Vertex Pharmaceuticals Inc has grown by 179.17%, going from $5.33 to $14.88. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $15.55 – an increase of 4.50%.Vertex Pharmaceuticals Incorporated live price charts and stock performance over time. ... VRTX Vertex Pharmaceuticals Incorporated . Overview . Chart . Analysis . News . Stats . Trade. Buy . 1m 5m 10m 15m 30m 1h 4h 1D 1W . 1D . ProCharts . S 348.75 B 350.02 . The chart contains indicative bid data that is not for trade use. dental plans in ncnasdaq crmt VRTX currently has a PEG ratio of 2.10. Another notable valuation metric for GSK is its P/B ratio of 4.69. Investors use the P/B ratio to look at a stock's market value versus its book value ... amc stock predictions The price-to-earnings ratio for Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) is above average at 26.34x. The 36-month beta value for VRTX is also noteworthy at 0.41. There are mixed opinions on the stock, with 19 analysts rating it as a “buy,” 3 rating it as “overweight,” 9 rating it as “hold,” and 0 rating it as “sell.”.Find the latest Vortex Energy Corp. (VRTX.CN) stock quote, history, news and other vital information to help you with your stock trading and investing.